SEP 21, 2020 8:11 PM PDT

Metformin Does Not Work in All Type 2 Diabetics

WRITTEN BY: Nouran Amin

Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all type 2 individuals.

"Our study constitutes an important step towards the goal of personalized care for diabetes patients because it can contribute to ensuring that the right person receives the right care as soon as there is a diagnosis," says Charlotte Ling, professor of epigenetics at Lund University, who led the study.

Examining the effects of metformin on different patients is the first pharmacoepigenetic study in diabetes. The study looked over epigenetic factors, DNA methylation, and biomarkers.

"If it takes a long time for the patient to receive the correct treatment, there is a risk of complications due to the elevated blood sugar levels. Approximately 30 per cent of all patients with type 2 diabetes do not respond to metformin and should be given another drug right from the start. For this reason, it is important to be able to identify these patients upon diagnosis," says Charlotte Ling.

Learn more about pharmacogenomics:

"To a certain extent, pharmacoepigenetics has been used within cancer care to predict how a person will respond to a treatment, however, it has never been done in diabetes care before," says Charlotte Ling.

Source: Science Daily

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUL 05, 2021
Drug Discovery & Development
ADHD Drug Reduces Daydreaming, Fatigue and Boredom
JUL 05, 2021
ADHD Drug Reduces Daydreaming, Fatigue and Boredom
Researchers led by New York University have found that a stimulant drug may be able to treat persistent daydreaming, fat ...
JUL 05, 2021
Cannabis Sciences
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
JUL 05, 2021
Long Term CBD Use Linked to Less Pain, Anxiety and Depression
Researchers from Canada have found that long-term use of cannabidiol (CBD) is linked to improved symptoms of pain, anxie ...
JUL 05, 2021
Neuroscience
People with Autism More Likely to Self-Medicate with Recreational Drugs
JUL 05, 2021
People with Autism More Likely to Self-Medicate with Recreational Drugs
Researchers from the University of Cambridge have found that people with autism are more likely than people without the ...
AUG 08, 2021
Microbiology
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
AUG 08, 2021
Manganese Could be an Achilles' Heel for Some Pneumonia Germs
Researchers recently discovered bacteria that fed on the element manganese. Scientists also know that some bacterial pat ...
AUG 17, 2021
Drug Discovery & Development
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
AUG 17, 2021
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
     Being tired throughout the day is a common feeling for most individuals. In fact, 1 out of every 5 A ...
AUG 26, 2021
Microbiology
Some Herbal Medicines May Help Treat Tick-Borne Diseases
AUG 26, 2021
Some Herbal Medicines May Help Treat Tick-Borne Diseases
Ticks are vectors for disease; they can transmit pathogenic bacteria to animals and humans through their bites. Diseases ...
Loading Comments...